Share This Page
Drug Price Trends for GUAIFENESIN-DM
✉ Email this page to a colleague

Average Pharmacy Cost for GUAIFENESIN-DM
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
GUAIFENESIN-DM 100-10 MG/5 ML CUP | 57237-0312-51 | 0.39945 | ML | 2025-01-22 |
GUAIFENESIN-DM 100-10 MG/5 ML CUP | 57237-0312-51 | 0.39945 | ML | 2024-12-18 |
GUAIFENESIN-DM 100-10 MG/5 ML | 58657-0505-08 | 0.02417 | ML | 2024-09-18 |
GUAIFENESIN-DM 100-10 MG/5 ML | 58657-0504-08 | 0.02417 | ML | 2024-09-18 |
GUAIFENESIN-DM 100-10 MG/5 ML | 58657-0504-08 | 0.02375 | ML | 2024-08-21 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Global Guaifenesin Market Analysis and Price Projections
Introduction to Guaifenesin
Guaifenesin is a widely used expectorant that facilitates the clearance of mucus in patients with productive coughs, enhancing respiratory comfort. It is commonly used in the treatment of cough, nasal congestion, and other respiratory issues, often in combination with other active ingredients like pseudoephedrine and dextromethorphan.
Market Size and Growth
The global guaifenesin market is experiencing significant growth driven by several key factors.
- Market Size: The global guaifenesin market is expected to reach US$ 2.7 billion by 2033, growing at a CAGR of 7.4% from 2023 to 2033, starting from a revenue of US$ 1.3 billion in 2023[1].
- API Market: The global guaifenesin API market was valued at approximately USD 500 million in 2023 and is projected to reach around USD 850 million by 2032, indicating a robust growth trajectory[3].
Key Drivers of the Market
Increasing Demand for Respiratory Health Products
The COVID-19 pandemic has highlighted the importance of maintaining good respiratory health, leading to an increased demand for expectorant drugs like guaifenesin. This trend is expected to continue, driving market growth[2].
Pharmaceutical and Biotech Advancements
Advancements in pharmaceutical and biotechnology sectors, including the development of new drug formulations and the approval of OTC equivalents, are boosting the market. For example, the FDA approval for Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets) in 2018 has been a significant driver[2].
Geographical Growth
- North America: This region is leading the guaifenesin market with the highest revenue share of 39.7% due to increased incidences of respiratory conditions and heightened awareness of respiratory health partly due to the COVID-19 pandemic[1].
- Asia Pacific: Expected to grow with the fastest CAGR, driven by the rising prevalence of respiratory ailments and expanding pharmaceutical manufacturing capabilities. Countries like India and China are reporting significant annual production growth[1][4].
Market Segmentation
By Product Type
- Tablets: Held a market share of 42.7% in 2023, leading the product type segment[1].
- Granules: Another popular form, especially for its convenience in dissolving.
- Syrups: Commonly used for pediatric and geriatric populations.
- Others: Includes extended-release formulations and combination products.
By Application
- Mucolytic Agent: Guaifenesin is primarily used as a mucolytic agent to facilitate mucus clearance.
- Cough Suppressant: Held a significant share of 48.3% in the application segment, often used in combination with dextromethorphan[1].
- Others: Includes various other respiratory health applications.
By Distribution Channel
- Hospital Pharmacies: Dominant player with the largest revenue share of 46.5% in the guaifenesin market, driven by increasing hospital admissions for respiratory infections and chronic pulmonary diseases[1].
- Retail Pharmacies: Significant segment due to the ease of access and over-the-counter availability.
- Online Pharmacies: Growing segment due to the proliferation of e-commerce platforms and increased consumer convenience[1].
Price Projections and Cost Analysis
Current Pricing
- The cost for guaifenesin/pseudoephedrine (600 mg-60 mg) oral tablet, extended release, is around $11 for a supply of 18 tablets, depending on the pharmacy and the use of discount cards[2].
- The cost for dextromethorphan/guaifenesin (10 mg-100 mg/5 mL) oral liquid is around $12 for a supply of 473 milliliters[5].
Future Pricing Trends
Future pricing trends may be influenced by several factors:
- Regulatory Changes: Negotiations and price controls, such as those implemented by the Medicare Drug Price Negotiation Program, could impact the pricing of prescription drugs, including guaifenesin/pseudoephedrine combinations[2].
- Market Competition: The availability of substitutes and generic versions could pressure prices downward.
- Demand and Supply Dynamics: Increased demand due to pandemics and other health crises could lead to temporary price fluctuations[2].
Challenges and Restraints
Availability of Substitutes
The global guaifenesin market faces challenges from the availability of substitute drugs, which can act as a restraint on market growth[2].
Potential Side Effects
Guaifenesin, like any medication, can have side effects, which may deter some consumers and impact market growth[2].
Stringent Regulations
Stringent regulations against certain cough suppressants can also pose challenges to the market[2].
Regional Analysis
North America
North America dominates the market with the highest revenue share due to increased incidences of respiratory conditions and heightened awareness of respiratory health. The American Hospital Association reported a significant increase in hospital drug expenses, highlighting the rising costs associated with respiratory treatments[1].
Asia Pacific
The Asia Pacific region is expected to experience the highest CAGR during the forecast period. Rapid urbanization and increasing pollution levels in countries like China and India have led to a higher incidence of respiratory issues, boosting demand for expectorants. India and China are the largest producers and consumers, with production volumes growing by 12% annually[1][4].
Key Players and Market Share
Top companies in the guaifenesin API market include Granules and Synthokem Labs, collectively accounting for 35% of the market share. Other significant players include Haizhou Pharma, Yuan Cheng Group, and Stellar Chemical[4].
Impact of COVID-19
The COVID-19 pandemic has significantly impacted the guaifenesin market by creating a surge in demand for cough and cold medications. This increased demand has driven market growth, although initial disruptions in production and supply chains were observed[2].
Consumer Awareness and Digital Platforms
Growing consumer awareness of effective expectorants and the proliferation of e-commerce platforms have enhanced accessibility and consumer engagement. Digital platforms have boosted sales by 15% year-on-year, contributing to market expansion[4].
Key Takeaways
- The global guaifenesin market is projected to reach US$ 2.7 billion by 2033, growing at a CAGR of 7.4% from 2023 to 2033.
- North America leads the market, while the Asia Pacific region is expected to grow with the fastest CAGR.
- Hospital pharmacies dominate the distribution channel segment.
- The market is driven by increasing demand for respiratory health products, pharmaceutical advancements, and geographical growth.
- Challenges include the availability of substitutes, potential side effects, and stringent regulations.
FAQs
Q: What is the projected market size of the global guaifenesin market by 2033?
A: The global guaifenesin market is forecasted to reach US$ 2.7 billion by 2033, growing at a CAGR of 7.4% from 2023 to 2033[1].
Q: What are the main drivers of the guaifenesin market?
A: The main drivers include increasing demand for respiratory health products, pharmaceutical and biotech advancements, and geographical growth, particularly in North America and the Asia Pacific region[1][2][4].
Q: How has the COVID-19 pandemic impacted the guaifenesin market?
A: The pandemic has created a surge in demand for cough and cold medications, leading to growth opportunities in the market. However, it also caused initial disruptions in production and supply chains[2].
Q: What are the challenges faced by the guaifenesin market?
A: The market faces challenges from the availability of substitutes, potential side effects, and stringent regulations against certain cough suppressants[2].
Q: What are the future pricing trends for guaifenesin/pseudoephedrine combinations?
A: Future pricing trends may be influenced by regulatory changes, market competition, and demand and supply dynamics. Current prices are relatively stable, but these could fluctuate based on these factors[2].
Cited Sources
- Market.us, "Guaifenesin Market Size, Share | CAGR Of 7.4%".
- Drugpatentwatch.com, "Pharmaceutical drug prices and trends for SM GUAIFENESIN-PSE ER".
- Dataintelo.com, "Guaifenesin (API) Market Research Report 2032".
- Globalgrowthinsights.com, "Guaifenesin (API) Market Size, Share & Trends Analysis, 2025-2033".
- Drugs.com, "Dextromethorphan/guaifenesin Prices, Coupons, Copay Cards & Patient Assistance".
More… ↓